News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
May, 2025
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Vivek Subbiah: Cancer Treatment Paradigms in The Precision Medicine Era
Vivek Subbiah/LinkedIn
May 21, 2025, 08:22

Vivek Subbiah: Cancer Treatment Paradigms in The Precision Medicine Era

Vivek Subbiah, Chief of Early-Phase Drug Development at Sarah Cannon Research Institute, posted on LinkedIn:

“Exciting Nature Medicine Publication Announcement!!!

Hot off the press on this Clinical Trials Day! Thrilled to share our Nature Medicine paper: “Cancer treatment paradigms in the precision medicine era”.

  • We propose 5 BOLD strategic recommendations to modernize cancer care-moving from one-size-fits-all to truly personalized interventions.
  • In this work, we address the critical need to evolve beyond traditional cancer treatment approaches.
  • The precision medicine revolution is transforming oncology, but fully implementing these advances requires systematic changes in how we approach treatment paradigms. Our paper outlines a roadmap for this transformation.”

Title: Cancer treatment paradigms in the precision medicine era.

Authors: Vivek Subbiah, Giuseppe Curigliano, Jason K. Sicklick, Shumei Kato, Kjetil Tasken, Arielle Medford, Damian T. Rieke, Hui-Zi Chen, Adam Wahida, Lars Buschhorn, Denis Horgan and Razelle Kurzrock

Read The Full Article at Nature Medicine.

Vivek Subbiah: Cancer Treatment Paradigms in The Precision Medicine Era

More posts featuring Vivek Subbiah.

Adam Wahida Arielle Medford cancer Clinical Trials Day Damian T. Rieke Denis Horgan Giuseppe Curigliano Hui Zi Chen Jason K. Sicklick Kjetil Tasken Lars Buschhorn Nature Medicine OncoDaily Oncology Precision Medicine Razelle Kurzrock Shumei Kato Vivek Subbiah
Special Coverage
Science
May 21, 2025, 08:22
Vivek Subbiah: Cancer Treatment Paradigms in The Precision Medicine Era
Blog
May 21, 2025, 08:19
GAMPER Webinar June 2025: Radiobiological Aspects of Radiotherapy and the Potential for Hypofractionation
Blog
May 21, 2025, 08:19
Cathy Eng: Two of my earlyonset Colorectal Cancer patients were honored at this annual run in Owensboro
Blog
May 21, 2025, 08:07
Amy Comander: Honored to Volunteer at Roxbury Community Health Fair
Blog
May 21, 2025, 08:02
Catherine Alix-Panabières: Honored to Highlight Our Research on Liquid Biopsy at the CHU de Montpellier
Blog
May 21, 2025, 07:53
Helena Linardou: Last Chance to Vote for the IASLC Board Election by May 22
Blog
May 21, 2025, 07:32
Ruben Mesa: Grateful to Take On a New Role as Clinical Leader for Advocate Health’s National Cancer Program
Blog
May 21, 2025, 07:25
Benedikt Westphalen Shares Final ESMO Recommendations for Molecular Tumour Boards
Blog
May 21, 2025, 07:16
Albert Koong: A Gathering of MD Anderson Physicists Could Disturb the Force
Blog
May 21, 2025, 07:09
Daniel Sumarriva: I’m Starting a New Position as Executive Medical Director at SAGA Diagnostics
Blog
May 21, 2025, 07:01
Together, She Changed Everything: Martine Piccart’s Fight Against Breast Cancer - CancerWorld
Blog
May 21, 2025, 06:44
Vivek Subbiah: Clinical Trials are Essential for Medical Advancement